Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.73% |
| 2 | Energy | 8.89% |
| 3 | Industrials | 8.57% |
| 4 | Technology | 7.69% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
4026
Franklin Street Properties
FSP
$50.8M
| $338K | ﹤0.01% |
31,463
-18,907
| -38% | -$199K |
|
4027
Kimbell Royalty Partners
KRP
$1.52B
| $338K | ﹤0.01% |
20,750
+5,850
| +39% | +$97.2K |
|
|
DTF
4028
DTF Tax-Free Income 2028 Term Fund
DTF
| $337K | ﹤0.01% |
23,943
-5,692
| -19% | -$80.8K |
|
|
KTF
4029
DWS Municipal Income Trust
KTF
$352M
| $337K | ﹤0.01% |
28,313
-150,672
| -84% | -$1.81M |
|
|
MFM
4030
Aberdeen Municipal Income Fund
MFM
$226M
| $337K | ﹤0.01% |
49,040
+700
| +1% | +$4.88K |
|
|
AM
4031
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $337K | ﹤0.01% |
11,606
+4,947
| +74% | +$142K |
|
4032
Cass Information Systems
CASS
$748M
| $336K | ﹤0.01% |
6,900
-331
| -5% | -$16.5K |
|
4033
LeMaitre Vascular
LMAT
$1.88B
| $336K | ﹤0.01% |
10,569
+2,240
| +27% | +$76.7K |
|
4034
Option Care Health
OPCH
$3.59B
| $336K | ﹤0.01% |
28,808
+1,252
| +5% | +$12.6K |
|
|
INSY
4035
DELISTED
Insys Therapeutics, Inc.
INSY
| $335K | ﹤0.01% |
34,829
+5,727
| +20% | +$37.5K |
|
|
HDNG
4036
DELISTED
Hardinge Inc
HDNG
| $335K | ﹤0.01% |
19,250
-1,157
| -6% | -$19.1K |
|
|
EDD
4037
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$372M
| $334K | ﹤0.01% |
43,418
-6,656
| -13% | -$52K |
|
4038
CALL
Kinder Morgan
KMI
$73.1B
| $334K | ﹤0.01% |
18,500
-162,500
| -90% | -$2.92M |
|
4039
Oxford Square Capital
OXSQ
$157M
| $334K | ﹤0.01% |
58,208
+960
| +2% | +$5.99K |
|
4040
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.08B
| $334K | ﹤0.01% |
5,133
-69
| -1% | -$4.43K |
|
|
CAA
4041
DELISTED
CalAtlantic Group, Inc.
CAA
| $334K | ﹤0.01% |
5,919
-46,616
| -89% | -$2.28M |
|
4042
UFP Industries
UFPI
$4.96B
| $333K | ﹤0.01% |
8,828
-9,784
| -53% | -$360K |
|
4043
CALL
Carnival Corporation Ltd
CCL
$38.5B
| $332K | ﹤0.01% |
5,000
-25,100
| -83% | -$1.66M |
|
|
SPWR
4044
DELISTED
SunPower Corporation Common Stock
SPWR
| $332K | ﹤0.01% |
60,098
-14,733
| -20% | -$76.3K |
|
|
EVRI
4045
DELISTED
Everi Holdings
EVRI
| $331K | ﹤0.01% |
43,800
-2,488
| -5% | -$20.1K |
|
4046
Graham Corp
GHM
$1.34B
| $331K | ﹤0.01% |
15,817
+2,758
| +21% | +$55.8K |
|
4047
CALL
Jefferies Financial Group
JEF
$12.7B
| $331K | ﹤0.01% |
+13,964
| New | +$322K |
|
4048
AMN Healthcare
AMN
$1.34B
| $330K | ﹤0.01% |
6,714
-10,611
| -61% | -$484K |
|
4049
CALL
3M
MMM
$94.2B
| $330K | ﹤0.01% |
1,674
+1,554
| +1,295% | +$299K |
|
4050
Xenon Pharmaceuticals
XENE
$6.03B
| $330K | ﹤0.01% |
116,692
+75,519
| +183% | +$205K |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.